Silence Therapeutics plc Operating Lease Cost
Silence Therapeutics plc (SLN) reported Operating Lease Cost of $197.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-05
- Silence Therapeutics plc operating lease, cost for fiscal 2025 was $197.00K, a 20.56% decline from fiscal 2024.
- Silence Therapeutics plc operating lease, cost for fiscal 2024 was $248.00K, a 2.48% increase from fiscal 2023.
- Silence Therapeutics plc operating lease, cost for fiscal 2023 was $242.00K, a 202.50% increase from fiscal 2022.
- Silence Therapeutics plc operating lease, cost for fiscal 2022 was $80.00K.
| Period end | Operating Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $197.00K 10-K · filed 2026-03-05 |
| 2024-12-31 | $248.00K 10-K · filed 2026-03-05 |
| 2023-12-31 | $242.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | $80.00K 10-K · filed 2025-02-27 |